Lutein Encyclopedia — Scientific Background

What Is Lutein?

Lutein (CAS 127-40-2) is a naturally occurring xanthophyll carotenoid and one of the two primary carotenoids (along with zeaxanthin) selectively concentrated in the human macula. It is a fat-soluble compound with the molecular formula C₄₀H₅₆O₂ and a molecular weight of 568.85 g/mol. Lutein is present in high concentrations in the human retina, where it serves as a natural blue light filter and antioxidant.

Botanical Source

Lutein is commercially extracted from the petals of marigold (Tagetes erecta L.), which is known to be the richest natural source of lutein. The extract from marigold flower contains approximately 93% utilizable pigments (detected at 450 nm), consisting of all-trans and cis isomers of zeaxanthin (5%), and all-trans and cis isomers of lutein and lutein esters (88%). African marigold (Tagetes erecta L.), a highly valued ornamental flower globally, is known to be the richest source of lutein, a natural colorant possessing substantial antioxidant activity.

The Macular Pigment and Blue Light Filtration

Lutein and zeaxanthin are the only two dietary carotenoids selectively accumulated in the human macula, where they form the macular pigment. This pigment serves as a natural optical filter, absorbing high-energy blue light (wavelengths 400–500 nm) before it reaches the photoreceptor cells. Lutein can filter up to 90% of high-energy blue light from the visible light spectrum. By filtering blue light, lutein protects the retina from photo-oxidative damage that can contribute to age-related macular degeneration (AMD) and other eye conditions.

Lutein is also found in the lens of the eye, where it contributes to antioxidant protection against cataract formation.

Mechanisms of Action

Antioxidant Defense

Lutein is a potent antioxidant that neutralizes reactive oxygen species (ROS) and reactive nitrogen species (RNS). It protects cellular membranes from lipid peroxidation and reduces oxidative stress in the eyes and skin. Lutein‘s antioxidant activity is particularly important in the retina, where high oxygen tension and constant light exposure generate significant oxidative stress.

Blue Light Filtration

The macular pigment formed by lutein and zeaxanthin acts as a short-wavelength light filter, reducing chromatic aberration and photic damage to the retina. This optical filtration function is complementary to lutein’s antioxidant role, providing both physical and biochemical protection to the retina.

Anti-Inflammatory Effects

Lutein has demonstrated anti-inflammatory properties, modulating inflammatory pathways and reducing the production of pro-inflammatory cytokines. This contributes to its protective effects in ocular and systemic tissues.

Cognitive Function

Lutein is the dominant carotenoid in the human brain, where it is consistently associated with all cognitive performance indicators. Research on lutein and cognitive function has shown that supplementation with lutein (10–20 mg/day) for 12 months in elderly adults may support cognitive performance.

The Bioavailability Challenge

Despite its important physiological functions, native lutein presents significant bioavailability challenges. Lutein is a fat-soluble compound with poor aqueous solubility, and its oral absorption is generally low (estimated at 5–20% of an oral dose) and highly variable among individuals. Lutein absorption requires consideration of both micellar and chylomicron formation, as lutein and zeaxanthin exhibit higher bioavailability when combined with fats or lipids.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects lutein during digestive transit, enhances dispersibility in aqueous systems, and facilitates efficient cellular uptake. Liposomal lutein has been shown to improve lutein stability in simulated digestion, with a 7.59-fold increase in bioaccessibility compared to free lutein.

Liposomal Lutein

Liposomal encapsulation of lutein provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the lutein molecule, forming a shield that protects it from degradation and enhances absorption. This delivery system:

• Enhances lutein solubility and dispersibility in aqueous systems

• Protects lutein from heat, light, and oxidative degradation

• Improves intestinal absorption through lipid-mediated pathways

• Provides superior bioavailability compared to conventional lutein forms

Reconstituted liposomal lutein formulations form stable nanoscale dispersions with a mean hydrodynamic diameter of 182.4 ± 4.1 nm, a polydispersity index of 0.212 ± 0.016, and a zeta potential of −34.7 ± 1.8 mV, confirming the presence of phospholipid vesicles rather than solid lipid nanoparticles or surfactant micelles. The liposomal powder contains mainly zwitterionic phosphatidylcholine and a small amount of negatively charged phosphatidylglycerol, reconstituting easily in water to form a stable nanoscale dispersion.

Clinical Evidence

AREDS2 Clinical Trial

The Age-Related Eye Disease Study 2 (AREDS2) was a major clinical trial conducted by the National Eye Institute (NEI). The study evaluated lutein (10 mg) + zeaxanthin (2 mg) supplementation in patients with age-related macular degeneration. Subgroup analysis showed that replacing beta-carotene with lutein/zeaxanthin reduced the risk of AMD progression by 18%. Patients with the lowest baseline level of lutein and zeaxanthin in their diets who added the supplement showed a 26% reduction of risk for AMD progression. Based on these findings, the NEI research authors recommend adding 10 mg lutein and 2 mg zeaxanthin and removing beta-carotene from the current dietary supplement formula.

Liposomal Lutein Absorption

A liposomal lutein ingredient (LUZvision) has been clinically shown to have an absorption rate approximately 4.8 times higher than conventional lutein. LUZvision is a free lutein powder extracted from marigold and combined with zeaxanthin in a 5:1 ratio, the optimal proportion backed by AREDS2. By encapsulating the powder with medium-chain triglycerides (MCTs) and phospholipids (liposomes), its bioavailability and water solubility is enhanced, and it can dissolve in chilled water and remain stable during heating, storage, and processing.

Pharmacokinetic Evidence

A comparative pharmacokinetic study in SD rats evaluated phospholipid, liposomal, and MCT formulations of lutein and zeaxanthin. The phosphatidylserine (PS) based vehicle yielded approximately 26% higher AUC₀–ₜ and 32% higher Cmax than the MCT-only control. The PC-enriched oil and liposomal powder also produced higher Cmax and AUC than the control (p < 0.01). Elimination kinetics remained consistent across all groups (Kel ≈ 0.08 h⁻¹; t1/2 ≈ eight hours), confirming that increased systemic exposure resulted from improved absorption rather than changes in metabolism or clearance.

Safety and Regulatory

Lutein is generally well tolerated at dietary and supplemental intake levels. The AREDS2 trial used 10 mg lutein daily for 5 years with no significant adverse effects reported. Lutein is widely commercialized as a dietary supplement ingredient and food colorant. In the United States, lutein is generally recognized as safe (GRAS) for use in food and dietary supplements. Lutein esters and free lutein have established safety records for use in nutraceutical and functional food applications. Formulators should verify local regulatory requirements prior to market entry. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

229$/KG

189$/KG